TY  - JOUR 
AU  - Domingo, Christian
AU  - Pomares, Xavier
AU  - Navarro, Albert
AU  - Rudi, Núria
AU  - Sogo, Ana
AU  - Dávila González, Ignacio Jesús
AU  - Mirapeix, Rosa
PY  - 2017
UR  - http://hdl.handle.net/10366/140733
AB  - [EN] Omalizumab is marketed for chronic severe asthma patients who are allergic to perennial
allergens. Our purpose was to investigate whether omalizumab is also effective in persistent severe
asthma due to seasonal allergens. Thirty patients with...
LA  - eng
KW  - Severe allergic asthma
KW  - Seasonal
KW  - Perennial
KW  - Omalizumab
KW  - Pathophysiology
KW  - Allergy and Immunology
TI  - Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study
DO  - 10.3390/ijms18030521
T2  - International Journal of Molecular Sciences
VL  - 18
M2  - 521
ER  -